CUMBERLAND PHARMACEUTICALS INC
bd_50cd510e5e7feb21 · schema v1 · pii pii-v1
Full breach record for CUMBERLAND PHARMACEUTICALS INC →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group BianLian on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Cumberland Pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. Cumberland is dedicated to providing high quality products which address unmet medical needs.
Source provenance
- Source URL
- https://www.ransomware.live/id/Q3VtYmVybGFuZCBQaGFybWFjZXV0aWNhbHMgSW5jLkBiaWFubGlhbg==
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Jul 19, 2023
- Raw hash
- 8be5620da18b7ab26faa4642734f1ca5944e8d7e51eee116875806617e0f9887
Reporting entity
- Name
- bianlian
Victim entity
- Name
- CUMBERLAND PHARMACEUTICALS INCnorm: cumberland pharmaceuticals
- Domain
- cumberlandpharma.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· bianlian
- Threat actor
- BianlianExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.